study cohort cohort

Aliases

1,139 baseline participants, 1,148 persons, 1,953 patients, 14 alcoholic and 13 control cases, 15 probands and family members, 17,355 subjects, 188 subjects, 189 subjects, 19 participants, 2134 families, 23 laboratories cohort, 26 cohorts, 27 cases, 3,112 individuals, 3,315 individuals, 3,378 individuals, 3,816 individuals, 3.2 million individuals, 353 participants, 3589 individuals, 4,385 individuals, 410 subjects, 449 subjects, 50,222 subjects, 535 samples, 5441 individuals, 69 subjects, 766 subjects, Cohort 2, Diabetes Heart Studies, GWAS, N=406 men, Nr, Participants, Participants (n=1023), age at interview cohort, age cohort, clinical population of over 20,000 patients, cohort, cohort 1, cohort 2, cohort 3, cohort 4, cohort 5, cohort 6, cohort [19], cohort studies, cohort-level summary statistics, cohort-sequential approach, cohort1, cohort2, cohort3, cohort4, cohort5, cohort6, cohorts, depressed patients, eight cohorts, entire cohort, first cohort, genome-wide association scan, independent cohort, large cohort, large cohorts, multiple studies, original cohort, other cohorts, our cohorts, our students, our study cohort, participants, patient sample, patients, project, replication cases, replication sample, replication samples, sample, schizophrenia organoids, second cohort, seven studies, six additional cohorts, subjects, subjects from our study, the cohort, the study, these cohorts, this population, this study, total sample, working group dataset, younger panel, youngest cohort

Related entities (24)

Mentioned in (181)

Papers in which this entity is mentioned.

• Infant subcortical brain volumes associated with maternal obesity and diabetes: a large multicohort human study. (2026)
• Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis. (2026)
• Integrative epigenetics and transcriptomics identify aging genes in human blood. (2026)
• Consortium profile: the methylation, imaging and NeuroDevelopment (MIND) consortium. (2026)
• Alcohol use disorder is associated with altered frontomedial phase-amplitude coupling strength during resting state. (2026)
• Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort. (2026)
• Validation of the ND-PAE Diagnosis in Children with Heavy Prenatal Alcohol Exposure. (2026)
• Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases. (2025)
• Feasibility trial of the My Health Coach app for adults with fetal alcohol spectrum disorders. (2025)
• Associations between common genetic variants and income provide insights about the socio-economic health gradient. (2025)
• Extrachromosomal DNA-Driven Oncogene Spatial Heterogeneity and Evolution in Glioblastoma. (2025)
• Meta-analysis reveals differences in somatic alterations by genetic ancestry across common cancers. (2025)
• Trajectories of genetic risk across dimensions of alcohol use behaviors. (2025)
• Integrated single-cell multiomic profiling of caudate nucleus suggests key mechanisms in alcohol use disorder. (2025)
• Tumour-wide RNA splicing aberrations generate actionable public neoantigens. (2025)
• Multi-omic quantitative trait loci link tandem repeat size variation to gene regulation in human brain. (2025)
• Maternal and child immune profiles are associated with neurometabolite measures of early-life neuroinflammation in children who are HIV-exposed and uninfected: a South African birth cohort. (2025)
• Genome-wide association testing beyond SNPs. (2025)
• Parent-of-origin effects on complex traits in up to 236,781 individuals. (2025)
• Transcription start sites experience a high influx of heritable variants fueled by early development. (2025)
• Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma. (2024)
• Characteristics of the Symptoms of the Proposed ND-PAE Disorder in First Grade Children in a Community Sample. (2024)
• Integrative polygenic risk score improves the prediction accuracy of complex traits and diseases. (2024)
• Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach. (2024)
• Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer. (2024)
• A global multicohort study to map subcortical brain development and cognition in infancy and early childhood. (2024)
• The Polygenic Score Catalog: new functionality and tools to enable FAIR research. (2024)
• Detection and analysis of complex structural variation in human genomes across populations and in brains of donors with psychiatric disorders. (2024)
• Adaptive, Externalizing, and Internalizing Behavior of Children with Prenatal Alcohol Exposure: A Comparison of Three Parent-Report Questionnaires. (2024)
• Integrated Single-Cell Multiomic Profiling of Caudate Nucleus Suggests Key Mechanisms in Alcohol Use Disorder. (2024)
• Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium. (2024)
• Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme. (2024)
• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients (2023)
• Predicting tumour content of liquid biopsies from cell-free DNA. (2023)
• Heritable defects in telomere and mitotic function selectively predispose to sarcomas. (2023)
• Gene-alcohol interactions in birth defects. (2023)
• Guidelines for Evaluating the Comparability of Down-Sampled GWAS Summary Statistics. (2023)
• Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers. (2023)
• Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors. (2023)
• Single-molecule methylation profiles of cell-free DNA in cancer with nanopore sequencing. (2023)
• Prenatal alcohol exposure and cognition at midlife: Evidence of fluid cognition deficits in two cohorts. (2023)
• Genetic Influences on the Developing Young Brain and Risk for Neuropsychiatric Disorders. (2023)
• Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA. (2022)
• Alcohol-related dysmorphic features as predictors of neurodevelopmental delay in infants and preschool-aged children: Results from a birth cohort in Ukraine. (2022)
• Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking. (2022)
• Genome-wide mutational signatures in low-coverage whole genome sequencing of cell-free DNA. (2022)
• Association of Maternal and Child Anemia With Brain Structure in Early Life in South Africa. (2022)
• Explainable multiview framework for dissecting spatial relationships from highly multiplexed data. (2022)
• Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts. (2022)
• Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. (2022)
• Prenatal depression exposure alters white matter integrity and neurodevelopment in early childhood. (2022)
• Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. (2022)
• Principal Component Analyses (PCA)-based findings in population genetic studies are highly biased and must be reevaluated. (2022)
• The impact of micronutrient supplementation in alcohol-exposed pregnancies on reaction time responses of preschoolers in Ukraine. (2022)
• The impact of prenatal alcohol exposure on gray matter volume and cortical surface area of 2 to 3-year-old children in a South African birth cohort. (2022)
• Inferring gene expression from cell-free DNA fragmentation profiles. (2022)
• Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. (2022)
• Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
• Circulating Tumor DNA as a Biomarker in Patients With Stage III and IV Wilms Tumor: Analysis From a Children's Oncology Group Trial, AREN0533. (2022)
• Med-BERT: pretrained contextualized embeddings on large-scale structured electronic health records for disease prediction. (2021)
• Partner influence as a factor in maternal alcohol consumption and depressive symptoms, and maternal effects on infant neurodevelopmental outcomes. (2021)
• Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. (2021)
• Central white matter integrity alterations in 2-3-year-old children following prenatal alcohol exposure. (2021)
• Validity and Reliability of Executive Function Measures in Children With Heavy Prenatal Alcohol Exposure: Correspondence Between Multiple Raters and Laboratory Measures. (2021)
• Association Between Benzodiazepine or Z-Drug Prescriptions and Drug-Related Poisonings Among Patients Receiving Buprenorphine Maintenance: A Case-Crossover Analysis. (2021)
• Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. (2021)
• Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer. (2021)
• An fMRI investigation of neural activation predicting memory formation in children with fetal alcohol spectrum disorders. (2021)
• A practical guide to cancer subclonal reconstruction from DNA sequencing. (2021)
• Shared genetic risk between eating disorder- and substance-use-related phenotypes: Evidence from genome-wide association studies. (2021)
• Fetal Alcohol Exposure Alters BOLD Activation Patterns in Brain Regions Mediating the Interpretation of Facial Affect. (2021)
• A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas. (2021)
• Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. (2021)
• Whole-genome analysis reveals the contribution of non-coding de novo transposon insertions to autism spectrum disorder. (2021)
• Genetic association study of childhood aggression across raters, instruments, and age. (2021)
• Use of Telemedicine for the Physical Examination of Children With Fetal Alcohol Spectrum Disorders. (2021)
• Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity. (2021)
• Neuroimaging young children and associations with neurocognitive development in a South African birth cohort study. (2020)
• Validity of automated FreeSurfer segmentation compared to manual tracing in detecting prenatal alcohol exposure-related subcortical and corpus callosal alterations in 9- to 11-year-old children. (2020)
• Discovery of regulatory noncoding variants in individual cancer genomes by using cis-X. (2020)
• B cells and tertiary lymphoid structures promote immunotherapy response. (2020)
• Immuno-genomic landscape of osteosarcoma. (2020)
• Pan-cancer analysis of whole genomes. (2020)
• Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. (2020)
• Sibling comparisons elucidate the associations between educational attainment polygenic scores and alcohol, nicotine and cannabis. (2020)
• Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior. (2020)
• Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. (2020)
• Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers. (2020)
• A Prospective Comparison of Bipolar I and II Subjects With and Without Comorbid Alcohol Dependence From the COGA Dataset. (2020)
• Genome-wide meta-analysis of problematic alcohol use in 435,563 individuals yields insights into biology and relationships with other traits. (2020)
• Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity. (2019)
• Gestational age and socioeconomic status as mediators for the impact of prenatal alcohol exposure on development at 6 months. (2019)
• The mutational footprints of cancer therapies. (2019)
• Determining cell type abundance and expression from bulk tissues with digital cytometry. (2019)
• Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study. (2019)
• htsget: a protocol for securely streaming genomic data. (2019)
• How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemia. (2019)
• Risk and protective factors for child development: An observational South African birth cohort. (2019)
• Psychosocial moderation of polygenic risk for cannabis involvement: the role of trauma exposure and frequency of religious service attendance. (2019)
• Genome-wide cell-free DNA fragmentation in patients with cancer. (2019)
• Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. (2019)
• RNA sequence analysis reveals macroscopic somatic clonal expansion across normal tissues. (2019)
• Best practices for bioinformatic characterization of neoantigens for clinical utility. (2019)
• Pan-cancer whole-genome analyses of metastatic solid tumours. (2019)
• Genome-wide association analysis links multiple psychiatric liability genes to oscillatory brain activity. (2018)
• mSignatureDB: a database for deciphering mutational signatures in human cancers. (2018)
• Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. (2018)
• Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. (2018)
• Drakenstein Child Health Study (DCHS): investigating determinants of early child development and cognition. (2018)
• Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer. (2018)
• Genome-wide association study identifies a novel locus for cannabis dependence. (2018)
• Genome doubling shapes the evolution and prognosis of advanced cancers. (2018)
• Immune diversity sheds light on missing variation in worldwide genetic diversity panels. (2018)
• Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes. (2018)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes (2018)
• Predicting T cell recognition of MHC class I restricted neoepitopes. (2018)
• PDGFRA gene, maternal binge drinking and obstructive heart defects. (2018)
• Copy number signatures and mutational processes in ovarian carcinoma. (2018)
• The Use of Cardiac Orienting Responses as an Early and Scalable Biomarker of Alcohol-Related Neurodevelopmental Impairment. (2017)
• CRAVAT 4: Cancer-Related Analysis of Variants Toolkit. (2017)
• Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. (2017)
• Vitamin D Deficiency in Pregnant Ukrainian Women: Effects of Alcohol Consumption on Vitamin D Status. (2017)
• OncoKB: A Precision Oncology Knowledge Base. (2017)
• HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. (2017)
• The evolution of tumour phylogenetics: principles and practice. (2017)
• Universal Patterns of Selection in Cancer and Somatic Tissues. (2017)
• Facial Curvature Detects and Explicates Ethnic Differences in Effects of Prenatal Alcohol Exposure. (2017)
• The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies. (2017)
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
• Who's Who? Detecting and Resolving Sample Anomalies in Human DNA Sequencing Studies with Peddy. (2017)
• Reductions in Corpus Callosum Volume Partially Mediate Effects of Prenatal Alcohol Exposure on IQ. (2017)
• The impact of structural variation on human gene expression. (2017)
• A Decision Tree to Identify Children Affected by Prenatal Alcohol Exposure. (2016)
• Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. (2016)
• KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. (2016)
• Reference-based phasing using the Haplotype Reference Consortium panel. (2016)
• High-Accuracy HLA Type Inference from Whole-Genome Sequencing Data Using Population Reference Graphs. (2016)
• The Influence of Extrinsic Reinforcement on Children with Heavy Prenatal Alcohol Exposure. (2016)
• Landscape of somatic mutations in 560 breast cancer whole-genome sequences. (2016)
• Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
• A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease. (2016)
• FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. (2016)
• Outcome of Patients With Recurrent Osteosarcoma Enrolled in Seven Phase II Trials Through Children's Cancer Group, Pediatric Oncology Group, and Children's Oncology Group: Learning From the Past to Move Forward. (2016)
• Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
• Prognostic value of inflammation-based scores in patients with osteosarcoma. (2016)
• Quantifying Clonal and Subclonal Passenger Mutations in Cancer Evolution. (2016)
• Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. (2015)
• Recurrent somatic mutations in regulatory regions of human cancer genomes. (2015)
• Integrative clinical genomics of advanced prostate cancer. (2015)
• Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia. (2015)
• Parietal dysfunction during number processing in children with fetal alcohol spectrum disorders. (2015)
• Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth. (2015)
• Gender modulates the development of theta event related oscillations in adolescents and young adults. (2015)
• CONSERTING: integrating copy-number analysis with structural-variation detection. (2015)
• Germline Mutations in Predisposition Genes in Pediatric Cancer. (2015)
• Profiling tissue-resident T cell repertoires by RNA sequencing. (2015)
• Robust enumeration of cell subsets from tissue expression profiles. (2015)
• Comparison of RNA-seq and microarray-based models for clinical endpoint prediction. (2015)
• Comprehensive genomic profiles of small cell lung cancer. (2015)
• RADIA: RNA and DNA integrated analysis for somatic mutation detection. (2014)
• Dynamic analyses of alternative polyadenylation from RNA-seq reveal a 3'-UTR landscape across seven tumour types. (2014)
• Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. (2014)
• Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. (2014)
• An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. (2014)
• Clonal evolution in hematological malignancies and therapeutic implications. (2014)
• DNA-Mutation Inventory to Refine and Enhance Cancer Treatment (DIRECT): a catalog of clinically relevant cancer mutations to enable genome-directed anticancer therapy. (2013)
• A genome-wide association study of alcohol-dependence symptom counts in extended pedigrees identifies C15orf53. (2013)
• Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability. (2013)
• A simple consensus approach improves somatic mutation prediction accuracy. (2013)
• ACMG clinical laboratory standards for next-generation sequencing. (2013)
• A comparative analysis of algorithms for somatic SNV detection in cancer. (2013)
• Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. (2013)
• Along-tract statistics allow for enhanced tractography analysis. (2012)
• Effects of heavy prenatal alcohol exposure and iron deficiency anemia on child growth and body composition through age 9 years. (2012)
• Ultrasensitive detection of rare mutations using next-generation targeted resequencing. (2012)
• Patient-derived tumour xenografts as models for oncology drug development. (2012)
• Detectable clonal mosaicism from birth to old age and its relationship to cancer. (2012)
• VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. (2012)
• Prevalence of children with severe fetal alcohol spectrum disorders in communities near Rome, Italy: new estimated rates are higher than previous estimates. (2011)
• Diffusion tensor imaging of the cerebellum and eyeblink conditioning in fetal alcohol spectrum disorder. (2011)
• Infant Symbolic Play as an Early Indicator of Fetal Alcohol-Related Deficit. (2010)

Merged raw entities (96)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.